Trial Profile

Prospective study evaluating aflibercept in patients with recurrent or prolonged diabetic macular edema after vitrectomy

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 06 Dec 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Aflibercept (Primary)
Indications Diabetic macular oedema
Focus Therapeutic Use

Most Recent Events

04 Dec 2018 Status changed from recruiting to completed.
30 Jun 2016 Planned End Date changed from 1 Feb 2017 to 31 Mar 2019.
13 Feb 2015 Status changed from not yet recruiting to recruiting, as reported by University Hospital Medical Information Network - Japan.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com